Recommended

Discover how to overcome low affinity or poor TCR yields that are slowing you down in this upcoming webinar – register your details today
WEBINAR | Discover how advances can expand the possibilities for drug discovery, from target validation to preclinical development
Facing roadblocks in obesity drug discovery? Discover how integrated, validated strategies are helping teams accelerate development and reduce risk – register your details now
Unlock the science, strategy and real-world impact behind the next generation of precision therapies – access our new brand report now >>
Safety data is no longer just a regulatory checkbox – it’s a strategic advantage. Find out more in our upcoming webinar, register your details today
WEBINAR | Join top cancer researchers to explore advances transforming early discovery, from new targets and models to the therapies of tomorrow
news

Final agenda released for the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, 27-28 October 2015, Boston, USA

Posted: 13 July 2015 | Oxford Global

With four months to go until the Next Generation Sequencing USA Congress and co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences are delighted to announce the release of the final agenda…

With four months to go until the Next Generation Sequencing USA Congress and co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences are delighted to announce the release of the final agenda.

Over the two days, these prestigious Congresses will bring together over 200 senior level attendees from both academia and pharmaceutical companies to discuss the most pressing challenges and opportunities in NGS and Single Cell research.

Taking place on the 27th & 28th October 2015 at the Harvard Medical School in Boston, USA, streams across the two days include:

 

Reserve your FREE place

 


Are low affinity or poor TCR yields slowing you down?

Explore how CHO expression of soluble TCRs and TCR affinity maturation workflows via phage, serving as essential building blocks for early-stage TCR-TCE candidate generation.

22 October 2025 | 16:00 PM BST | FREE Webinar

Join Jiansheng Wu, Ph.D. to explore two integrated strategies:

  • High-titer CHO-based expression of sTCRs (~100 mg/L), enabling scalable and high-throughput production
  • Optimized phage display affinity maturation, improving TCR binding by up to ~10,000-fold

Whether you’re starting a new TCR program or optimizing an existing platform, this session will offer actionable strategies to accelerate discovery and improve candidate quality.

Register Now – It’s Free!

 

  • NGS Technologies & Platforms in Genomics and Genetics Research
  • NGS Data Analysis Technologies & Platforms
  • Latest Case Studies on Cancer Drug Development, Immunotherapy and Microbiology
  • NGS: Clinical Applications & Diagnostics
  • Single Cell Genomics, Transcriptomics, Proteomics
  • Single Cell Analysis Technologies and Clinical Applications

To view the final programme in full, along with the completed list of speakers, download the Congress agenda here: http://www.nextgenerationsequencingusa-congress.com/download-agenda-marketing/

In the run up to the event, we have also been discussing NGS and Single Cell developments with industry leaders speaking at the Congress. To view these Q&As in full, please visit: http://www.nextgenerationsequencingusa-congress.com/speakers/qa/

Register Today!

To register your interest in attending the Congress, please email Steph Punfield on [email protected] or call +44 (0)1865 248455. A limited number of group and individual discounts are available on a first-come-first-served basis – to find out more information, please email Steph on the email address above.

If you’re on Twitter, make sure to follow us on @NGSUSCongress and join the Congress conversation on #NGSUS15.